Adaptive radiotherapy for gynecological tumors
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a personalized radiation therapy approach for gynecological tumors. It aims to improve treatment by adapting the radiation plan based on changes in the tumor and nearby organs during your therapy course.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a gynecological tumor that has been confirmed by a tissue sample (biopsy) or MRI scan.
- Your cancer has not spread to other parts of the body (stage M0).
- You have not received radiation in the pelvic area before.
- You are in good physical condition, able to carry out everyday activities (ECOG 0 or 1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of radiation therapy that adjusts during treatment for head and neck tumors. It’s for people who haven’t had cancer treatment before and are otherwise in good health.
This trial tests a special type of radiation therapy that can adjust to changes in your tumor during treatment. It's for people with head or neck tumors who are scheduled for radiation.
This trial tests a shorter, personalized radiation schedule for cervical cancer. It uses daily CT scans to adjust the radiation beam for better targeting. It may mean fewer hospital visits and less damage to healthy tissue.
This trial tests whether a newer type of daily CT scan (CBCT-guided adaptive radiotherapy) can safely and accurately deliver radiation to cancers of the prostate, cervix, bladder, lung, or head and neck. The goal is to better target the tumor and reduce side effects.
This trial tests whether an “adaptive” type of radiation planning using proton therapy and MRI-guided brachytherapy can improve treatment for people with cervical cancer. It aims to deliver curative treatment more precisely while still combining it with chemotherapy (cisplatin) when appropriate.
This trial tests a special type of radiation called adaptive radiotherapy for people with certain pelvic cancers. Adaptive radiotherapy adjusts the treatment plan each day based on changes in your body, which may help target the cancer more precisely and reduce side effects.
Hear when a new Adaptive Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.